| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.073 | 0.2 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.2 |